O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
-0.47%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$5.5M
AUM Growth
+$5.5M
(-100%)
Cap. Flow
-$176M
Cap. Flow
% of AUM
-3,203.7%
Top 10 Holdings %
Top 10 Hldgs %
32.29%
Holding
153
New
11
Increased
26
Reduced
36
Closed
14
Top Buys
| 1 |
SVA
Sinovac Biotech, Ltd
SVA
|
$349K |
| 2 |
Xenon Pharmaceuticals
XENE
|
$19.6K |
| 3 |
Mersana Therapeutics
MRSN
|
$19.5K |
| 4 |
Travere Therapeutics
TVTX
|
$18.7K |
| 5 |
Progyny
PGNY
|
$18.2K |
Top Sells
| 1 |
DexCom
DXCM
|
$76.7M |
| 2 |
NSTG
NanoString Technologies, Inc.
NSTG
|
$40.2M |
| 3 |
Ultragenyx Pharmaceutical
RARE
|
$16.5M |
| 4 |
Illumina
ILMN
|
$15.8M |
| 5 |
Galapagos
GLPG
|
$12.9M |
Sector Composition
| 1 | Healthcare | 98.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
argenx
ARGX
$44.2B
| $73.5K | 1.33% |
194,000
+24,200
| +14% | +$9.17K |
|
|
MRTX
27
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $73.2K | 1.33% |
1,090,400
-540,100
| -33% | -$36.3K |
|
|
GBT
28
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $65.3K | 1.18% |
2,044,000
+467,400
| +30% | +$14.9K |
|
29
Thermo Fisher Scientific
TMO
$183B
| $61.6K | 1.12% |
113,400
-7,200
| -6% | -$3.91K |
|
30
Crinetics Pharmaceuticals
CRNX
$3.26B
| $59.6K | 1.08% |
3,196,876
| – | – |
|
31
Natera
NTRA
$23B
| $58.9K | 1.07% |
1,661,353
+65,968
| +4% | +$2.34K |
|
32
Compass Therapeutics
CMPX
$466M
| $58.2K | 1.05% |
21,960,850
+317,875
| +1% | +$842 |
|
33
Evolent Health
EVH
$1.11B
| $54.6K | 0.99% |
1,778,000
+378,000
| +27% | +$11.6K |
|
34
Prelude Therapeutics
PRLD
$69.1M
| $52.4K | 0.95% |
10,039,691
| – | – |
|
|
KNTE
35
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $51K | 0.92% |
4,043,629
| – | – |
|
36
Repare Therapeutics
RPTX
$73.9M
| $46.5K | 0.84% |
3,322,488
| – | – |
|
37
Keros Therapeutics
KROS
$640M
| $46.4K | 0.84% |
1,679,417
| – | – |
|
38
Syndax Pharmaceuticals
SNDX
$1.39B
| $44.7K | 0.81% |
2,323,300
+165,000
| +8% | +$3.18K |
|
39
AbCellera Biologics
ABCL
$1.19B
| $44.5K | 0.81% |
4,180,768
| – | – |
|
40
SI-BONE Inc
SIBN
$700M
| $44.5K | 0.81% |
3,368,000
+228,753
| +7% | +$3.02K |
|
|
GRCL
41
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $43.4K | 0.79% |
7,884,870
| – | – |
|
42
Guardant Health
GH
$8.11B
| $41.7K | 0.76% |
1,033,400
-292,000
| -22% | -$11.8K |
|
|
43
Mersana Therapeutics
MRSN
$34.8M
| $41.6K | 0.75% |
9,011,437
+4,222,537
| +88% | +$19.5K |
|
|
44
Xenon Pharmaceuticals
XENE
$2.99B
| $40.4K | 0.73% |
1,329,200
+643,200
| +94% | +$19.6K |
|
45
Xtant Medical Holdings
XTNT
$82.4M
| $37.9K | 0.69% |
72,943,918
| – | – |
|
46
ARS Pharmaceuticals
SPRY
$1.08B
| $37.1K | 0.67% |
8,740,887
| – | – |
|
|
VECT
47
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
| $35K | 0.63% |
6,473,561
+1,142,857
| +21% | +$6.17K |
|
|
ALPN
48
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $34.7K | 0.63% |
4,081,592
| – | – |
|
49
Janux Therapeutics
JANX
$1.38B
| $34.6K | 0.63% |
2,836,386
| – | – |
|
50
Tenet Healthcare
THC
$16.5B
| $34.5K | 0.63% |
656,300
+28,000
| +4% | +$1.47K |
|